home / stock / xrtx / xrtx news


XRTX News and Press, XORTX Therapeutics Inc. From 08/22/22

Stock Information

Company Name: XORTX Therapeutics Inc.
Stock Symbol: XRTX
Market: NASDAQ
Website: xortx.com

Menu

XRTX XRTX Quote XRTX Short XRTX News XRTX Articles XRTX Message Board
Get XRTX Alerts

News, Short Squeeze, Breakout and More Instantly...

XRTX - What Is Going on With Signify Health (SGFY) Stock Today?

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Chinnapong / Shutterstock.com Signify Health (NYSE: SGFY ) stock is climbing higher on Monday as investors react to reports that Amazon (NASDAQ: AMZN ) is bidding on the healthcare company . Acc...

XRTX - Why Is Xortx Therapeutics (XRTX) Stock Moving Today?

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Bukhta Yurii / Shutterstock.com Xortx Therapeutics (NASDAQ: XRTX ) stock is moving on Monday after the company reported positive results from a clinical trial . Those results come from the second stag...

XRTX - Xortx stock soars 40% as kidney disease drug shows promise in bridging study

Xortx Therapeutics ( NASDAQ: XRTX ) said its proprietary formulation of oxypurinol showed a substantial increase in oral bioavailability provided with food compared to the fasted state in a pharmacokinetics bridging study, dubbed XRX-OXY-101, Part 2. The comp...

XRTX - XORTX Announces Positive Topline Results from Part 2 Pharmacokinetics Bridging Study

CALGARY, Alberta, Aug. 22, 2022 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, is ...

XRTX - XORTX Announces Pre-Phase 3 Meeting Date with US Food and Drug Administration

CALGARY, Alberta, Aug. 04, 2022 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, is ...

XRTX - XORTX Announces Submission to European Medicines Agency

CALGARY, Alberta, July 19, 2022 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, ann...

XRTX - Sunrun, 10x Genomics, Innovative Industrial Properties among premarket losers' pack

Codexis ( CDXS ) -23% as forecast comes below estimates . 10x Genomics ( TXG ) -19% on guiding Q2 revenues below consensus . Innovative Industrial Properties ( IIPR ) -21% . Lantern Pharma ( LTRN ) -10% . Sunrun ( RUN ) -8%...

XRTX - Telefonaktiebolaget LM Ericsson, Harmony Gold Mining, BELLUS Health among premarket losers' pack

ContraFect ( CFRX ) -77% as data safety board recommends ending co's DISRUPT trial . BELLUS Health ( BLU ) -10% on pricing $153M stock offering in Canada, U.S. Telefonaktiebolaget LM Ericsson ( ERIC ) -9% on Q2 earnings release . Therape...

XRTX - XORTX Therapeutics leads healthcare gainers, Humanigen and Atara Biotherapeutics among losers

Gainers: XORTX Therapeutics ( XRTX ) +39% . Gossamer Bio ( GOSS ) +24% . Rhythm Pharmaceuticals ( RYTM ) +23% . Apollo Endosurgery ( APEN ) +18% . Tyra Biosciences ( TYRA ) +15% . Losers: Humanigen ( HGEN ) -80% . Atara Biotherap...

XRTX - XORTX jumps over 100% after early encouraging data for rare disease therapy

Nano-cap pharma XORTX Therapeutics ( NASDAQ: XRTX ) surged ~103% on above average volume in the pre-market Wednesday after the company announced encouraging results for the company’s oxypurinol formulation from a pharmacokinetics bridging study. The trial XRX-OX...

Previous 10 Next 10